In November 2018, Nutritional Medicinals, LLC (d.b.a. "Functional Formularies" or the “Company") announced a majority recapitalization transaction with Swander Pace Capital.
Founded in 2006 by professional chef and nutrition expert Robin Gentry McGee, Functional Formularies is the leading provider of organic, whole food, shelf-stable feeding tube formulas. Ms. Gentry McGee created the Company after searching unsuccessfully for natural alternatives to traditional feeding tube formulas to help her father when he was faced with life threatening health issues. The Company offers unique, organic, and whole food alternatives to traditional feeding tube formulas. Liquid Hope and Nourish are nutritionally complete, plant-based, and USDA-certified organic. The Company offers its products to retail customers online and to institutional customers in hospital and long-term care settings.
Duff & Phelps served as exclusive M&A advisor to Functional Formularies in connection with the transaction.
About Functional Formularies
Functional Formularies was founded in 2006 by Robin Gentry McGee who, over the past several decades, has developed a vast knowledge of the food as medicine model. Today, the privately held company serves thousands of customers, hospital formularies, and home health care organizations with Liquid Hope for adults and older children and Nourish for pediatrics, throughout the U.S., Canada, Australia, the U.K. and many other countries.
About Swander Pace Capital
Swander Pace Capital (SPC) is a private equity firm that invests in companies that are integral to consumers' lives. SPC's consumer industry expertise informs the firm's strategic approach and adds value through access to its proven SPC Playbook, senior team, and extensive network. The firm partners with management teams to help build companies to their full potential. SPC invests in businesses across three domains of consumer lifestyles: Food + Beverage, Body + Wellness, and Home + Family. With offices in San Francisco, New Jersey, and Toronto, SPC has invested in more than 50 companies and raised cumulative equity commitments of approximately $1.8 billion since 1996.
Corporate Finance and Restructuring
Comprehensive corporate finance, investment banking and restructuring services to investors, asset managers, companies and lenders.
Middle-market M&A advisory differentiated by industry expertise and superior deal execution.
Consumer, Food, Restaurants and Retail M&A
Consumer, Retail, Food and Restaurant expertise for middle-market M&A transactions.
Fairness and Solvency Opinions
Independent opinions for boards of directors and special committees.
Transaction Advisory Services
Seamless analytical advisory through the deal continuum, from transaction origination to closing.
Distressed M&A and Special Situations
Financial and operational solutions for distressed and special situations.
Private Capital Markets – Debt Advisory
Senior, subordinated and mezzanine debt and venture/private equity for a wide range of transactions.
Financial Sponsors Group
Dedicated coverage and access to M&A deal-flow for financial sponsors.
Insider Threat Indicators and Detection: When Employees Turn Ransomware Accomplices
The THIP Model: Embedding Emotional Intelligence in Third-Party Risk Management
Valuation Insights – Fourth Quarter 2021
Shannon Pratt’s "Valuing a Business" - Preserving a Legacy
Kroll Appoints David Lewis, Former Executive Secretary of the FATF, as a Managing Director to Lead its AML Advisory Practice
Who’s Who Legal Recognizes Six Kroll Professionals in the Fields of Financial Restructuring and Insolvency Worldwide
Prime Clerk, A Kroll Business, Welcomes Former Kirkland & Ellis Partner Brad Weiland to Its Team
Kroll Expands Cloud Security and Red Team Capabilities with Acquisition of Security Compass Advisory